USP's revised chapter on injectables could harm anticounterfeiting efforts and drug administration.
Frederick J. Balboni, Jr.
Advertisement
Frederick J. Balboni, Jr., is executive director of the Consortium for the Advancement of Patient Safety (CAPS).
Articles by Frederick J. Balboni, Jr.
Advertisement
Latest Updated Articles
Changes to Vial Labels May Affect Patient SafetyPublished: March 2nd 2009 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
PharmTech Weekly News Roundup – Week of November 3, 2025
2
AAPS PharmSci 360: Enhancing Bioanalysis with AI and Other Technologies
3
New Dosage Forms and Delivery Systems Driving 505(b)(2) Success
4
2025 AAPS PharmSci 360 to Highlight Next-Gen AI for Drug Development
5
